We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-9.55%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.91B
AUM Growth
-$872M
Cap. Flow
-$3.53M
Cap. Flow %
-0.05%
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
67
Closed
19

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$333M
2
PG icon
Procter & Gamble
PG
+$47.1M
3
CVS icon
CVS Health
CVS
+$42.1M
4
USB icon
US Bancorp
USB
+$40.8M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$10.8M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$355M
2
CL icon
Colgate-Palmolive
CL
+$27M
3
V icon
Visa
V
+$19.2M
4
ESRX
Express Scripts Holding Company
ESRX
+$9.59M
5
BMY icon
Bristol-Myers Squibb
BMY
+$7.46M

Sector Composition

Rank Sector Weight
1 Financials 22.69%
2 Consumer Discretionary 16.64%
3 Healthcare 14.3%
4 Communication Services 12.68%
5 Consumer Staples 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TD icon
76
Toronto Dominion Bank
TD
$195B
$2.12M 0.03%
31,209
+12,166
+64% +$666K
PODD icon
77
Insulet
PODD
$11.8B
$2.06M 0.03%
25,994
-9,221
-26% -$780K
IOVA icon
78
Iovance Biotherapeutics
IOVA
$2.03B
$2.01M 0.03%
226,681
-173,922
-43% -$1.68M
TVRD
79
Tvardi Therapeutics
TVRD
$22.1M
$1.99M 0.03%
4,256
-2,617
-38% -$1.69M
PGR icon
80
Progressive
PGR
$129B
$1.95M 0.03%
32,374
+11,470
+55% +$763K
ELV icon
81
Elevance Health
ELV
$82.4B
$1.93M 0.03%
7,364
– –
ARMK icon
82
Aramark
ARMK
$15B
$1.88M 0.03%
90,046
+33,843
+60% +$879K
NEO icon
83
NeoGenomics
NEO
$2.03B
$1.88M 0.03%
149,378
-52,993
-26% -$790K
VKTX icon
84
Viking Therapeutics
VKTX
$3.86B
$1.78M 0.03%
+232,138
New +$2.78M
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.67M 0.02%
146,671
-52,032
-26% -$840K
ONCE
86
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.63M 0.02%
41,624
-13,375
-24% -$580K
FNV icon
87
Franco-Nevada
FNV
$40.5B
$1.6M 0.02%
22,759
+8,000
+54% +$535K
FOMX
88
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.59M 0.02%
442,884
-157,116
-26% -$683K
CHRS icon
89
Coherus Oncology
CHRS
$217M
$1.54M 0.02%
170,525
-57,371
-25% -$664K
INSM icon
90
Insmed
INSM
$22.5B
$1.48M 0.02%
113,110
-127,532
-53% -$2.03M
STOR
91
DELISTED
STORE Capital Corporation
STOR
$1.43M 0.02%
50,360
– –
OTEX icon
92
Open Text
OTEX
$6.23B
$1.4M 0.02%
31,454
– –
ACHC icon
93
Acadia Healthcare
ACHC
$2.55B
$1.38M 0.02%
53,712
-19,055
-26% -$660K
VCRA
94
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.38M 0.02%
35,013
-23,332
-40% -$844K
AXDX
95
DELISTED
Accelerate Diagnostics
AXDX
$1.32M 0.02%
11,468
-4,069
-26% -$603K
STML
96
DELISTED
Stemline Therapeutics, Inc.
STML
$1.26M 0.02%
132,428
-46,981
-26% -$609K
CLVS
97
DELISTED
Clovis Oncology, Inc.
CLVS
$1.23M 0.02%
68,492
-22,664
-25% -$463K
ACRS icon
98
Aclaris Therapeutics
ACRS
$708M
$1.13M 0.02%
152,954
-52,797
-26% -$544K
PFNX
99
DELISTED
Pfenex Inc.
PFNX
$1.12M 0.02%
352,153
– –
ALL icon
100
Allstate
ALL
$71B
$1.12M 0.02%
+13,537
New +$1.22M
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2018 Portfolio in Review

As of Q4 2018, C WorldWide Group held 141 positions worth $6.91B, down 11% from $7.79B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q4 2018 filing shows 10 new, 20 increased, 67 reduced and 19 closed positions. Its largest new stake was American Tower: 2,128,357 shares worth $337M. The largest sale was Citigroup, an estimated $355M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q4 2018 buy was American Tower: 2,128,357 shares worth $337M.
  • C WorldWide Group added most to Procter & Gamble in Q4 2018, an estimated $47.1M increase.
  • C WorldWide Group's biggest Q4 2018 reduction was Visa, cutting an estimated $19.2M.
  • C WorldWide Group fully exited Citigroup in Q4 2018, selling an estimated $355M.
  • C WorldWide Group's ten largest holdings make up 71% of its $6.91B portfolio in Q4 2018.
  • C WorldWide Group opened 10 new positions and closed 19 in Q4 2018.
  • C WorldWide Group's portfolio value fell 11% quarter-over-quarter to $6.91B.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.